Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calmmax Cream in chronic uremic pruritus
NCT02032537Unknown
- Sponsor
- Shaare Zedek Medical Center
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Calmmax in uremic pruritus, sponsored by Shaare Zedek Medical Center. Primary endpoint: Visual Analog Scale reduction at 1 year. Status: unknown.
02
Drugs
Calmmax
03
Conditions
uremic pruritus
Beyond the preview
Go deeper on NCT02032537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032537.